Icon times
Non-Covid revenue for Thyrocare remains stable as margin take a hit in Q2 due to ESOP cost | Thyrocare Technologies Q2 FY23 Result & Earning Call Highlights

Non-Covid revenue for Thyrocare remains stable as margin take a hit in Q2 due to ESOP cost | Thyrocare Technologies Q2 FY23 Result & Earning Call Highlights

Published on 14 November 2022 .Views 0 .Comments 0
Share On
Attachments:
private article suscription area icon

You like to know more. We like that!

Please subscribe Model Portfolio Plan to get access of all premium model portfolio articles Only at Rs. 9,999.00/Year.

Please login to view this free article.

This blog is available only for logged in users, please register and get access to view this article.

Recently Uploaded

premium Premium
free Free
Chat on WhatsApp
Caret UP Arrow
InvestYadnya Support
Typically replies in minutes
InvestYadnya Support
Hi there
Welcome to InvestYadnya.
We are available to assist you on WhatsApp.
Please click on the button below to chat with us.
(10 AM to 7 PM IST)
16:10
Chat with InvestYadnya